sy-2101
Generic: Arsenic trioxide
sy-2101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Syros Pharmaceuticals, Inc. (SYRS) | Phase 1 |
Get deeper analysis on sy-2101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis